T3 Pharmaceuticals completes second financing round; Moderna, Harvard Medical School to tackle immunological diseases
→ University of Basel, Switzerland spinout T3 Pharmaceuticals has raised 12 million CHF at the close of its second financing round. Current …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
